FindTrial
Sign In

Clinical research of autoimmune metaplastic atrophic gastritis and related gastric diseases: a retrospective study based on medical records

Clinical research of autoimmune metaplastic atrophic gastritis and related gastric diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041163
Enrollment
Unknown
Registered
2020-12-20
Start date
2020-12-08
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune metaplastic atrophic gastritis

Interventions

Autoimmune metaplastic atrophic gastritis:Nil

Sponsors

Beijing Friendship Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with atrophic gastritis whose atrophic parts are mainly gastric fundus and body according to gastroscope; 2. Those patients with histopathological findings of atrophy of gastric fundus and body mucosa or with intestinal metaplasia, pancreatic acinar metaplasia and pseudopylorus metaplasia, with or without other pathological changes, such as gastric hyperplastic polyps, gastric neuroendocrine tumors, gastric dysplasia and early gastric cancer; 3. Patients with elevated serum gastrin or positive anti parietal cell antibody and anti endofactor antibody.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
serum gastrin-17;serum parietal cell antibody;serum intrinsic factor antibody;serum vitamin B12;serum iron;serum thyroid function and antibodies;serum H.pypori antibody;IHC of CgA;IHC of Syn;IHC of Ki-67;serum hemoglobin;—

Countries

China

Contacts

Public ContactHu Haiyi

Beijing Friendship Hospital Affiliated to Capital Medical University

werjw@126.com+86 13811185943

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026